HRMY - Harmony Biosciences Holdings Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-11-03    (Delayed quote data   2025-09-12)
Last
 32.39		 Change
 ⇓ -1.03   (-3.08%)		 Volume
  809,591
Open
 33.38		 High
 33.40		 Low
 32.30
8EMA (Daily)
 34.46		 40EMA (Daily)
 35.47		 50EMA (Daily)
 35.32		 STO (Daily)
 8.090		 MACD Hist (Daily)
 -1.216
8EMA (Weekly)
 35.166		 40EMA (Weekly)
 34.29		 50EMA (Weekly)
 34.22		 STO (Weekly)
 70.769		 MACD Hist (Weekly)
 0.018
Company Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com